BENSULFOID Drug Patent Profile
When do Bensulfoid patents expire, and when can generic versions of Bensulfoid launch?
Bensulfoid is a drug marketed by Poythress and is included in one NDA.
The generic ingredient in BENSULFOID is sulfur. There is one drug master file entry for this compound. Additional details are available on the sulfur profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BENSULFOID?
- What are the global sales for BENSULFOID?
- What is Average Wholesale Price for BENSULFOID?
Summary for BENSULFOID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 33 |
| DailyMed Link: | BENSULFOID at DailyMed |
US Patents and Regulatory Information for BENSULFOID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Poythress | BENSULFOID | sulfur | POWDER;TOPICAL | 002918-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
